Sherbrooke Park Advisers LLC Kura Oncology, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q3 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 13,299 shares of KURA stock, worth $148,948. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,299
Previous 18,619
28.57%
Holding current value
$148,948
Previous $107 Million
9.55%
% of portfolio
0.05%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding KURA
# of Institutions
212Shares Held
81.4MCall Options Held
900KPut Options Held
228K-
Bvf Inc San Francisco, CA8.62MShares$96.5 Million4.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.12MShares$90.9 Million2.16% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$78 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$61.2 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.67MShares$52.3 Million0.64% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $749M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...